DaVita Profile

USD 0.13  0.19%

Acquisition by William Roper of 1500 shares of DaVita subject to Rule 16b-3

DaVita insider trading alert for grant of common stock by William Roper, the corporate stakeholder, on May 23, 2018. This event was filed by Davita Inc with SEC on 2006-05-17. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

DaVita Summary

DaVita (DVA) is traded on New York Stock Exchange in USA. It is located in COLORADO, U.S.A and employs 74,500 people. DaVita is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 11.89 B. DaVita runs under Healthcare sector within Healthcare Services industry. This company has 174.5 M outstanding shares of which 0 shares are currently shorted by investors with about 0.0 days to cover shorted positions. DAVITA INC has about 363.48 M in cash with 1.47 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.08.
Check DaVita Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 67.96HorizonTargetOdds Above 67.96
87.86%30 days 67.96 11.95%
Based on normal probability distribution, the odds of DaVita to move above current price in 30 days from now is about 11.95% (This DaVita probability density function shows the probability of DaVita Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Berkshire Hathaway IncCommon Shares38.6 M2.5 B
Vanguard Group IncCommon Shares14.2 M938.5 M
View DaVita Diagnostics

Selected DaVita Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

DaVita Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for DaVita are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease . DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado. DaVita operates under Medical Care classification in USA and traded on New York Stock Exchange. It employs 74500 people. more
Fama & French Healthcare
Fama & French Classification
CEO of Kidney Care DivisionJavier RodriguezView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Healthcare Services
InstrumentUSA Stock View All
RegionNorth America
Business Address2000 16th Street
ExchangeNew York Stock Exchange
CIK Number00927066.0
IndustryHealthcare Services
Contact Number303 405 2100
CurrencyUSD - US Dollar


DaVita Analyst Recommendations
Target PriceAdvice# of Analysts
DaVita current and past analyst recommendations published by number of research institutions as well as average analyst consensus
DaVita Analyst Advice  


DaVita Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.82May 3, 2017
DaVita normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


DaVita Corporate Directors
Paul Diaz Independent Director
John Nehra Independent Director
Peter Grauer Lead Independent Director
Additionally see Investing Opportunities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.